Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 13 studies | 30% ± 15% | |
eye | 8 studies | 37% ± 15% | |
peripheral blood | 6 studies | 20% ± 5% | |
lung | 5 studies | 22% ± 4% | |
pancreas | 3 studies | 42% ± 12% | |
kidney | 3 studies | 17% ± 1% | |
intestine | 3 studies | 19% ± 2% | |
adipose | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1797.50 | 180 / 180 | 100% | 29.74 | 430 / 430 |
stomach | 100% | 1446.56 | 359 / 359 | 100% | 35.59 | 286 / 286 |
brain | 100% | 2449.02 | 2641 / 2642 | 100% | 94.05 | 705 / 705 |
lung | 100% | 2055.59 | 578 / 578 | 100% | 41.64 | 1153 / 1155 |
uterus | 100% | 2293.32 | 170 / 170 | 100% | 35.43 | 458 / 459 |
thymus | 100% | 1757.44 | 652 / 653 | 100% | 26.19 | 604 / 605 |
intestine | 100% | 2261.78 | 966 / 966 | 100% | 36.39 | 525 / 527 |
kidney | 100% | 2283.90 | 89 / 89 | 100% | 32.55 | 897 / 901 |
breast | 100% | 1887.83 | 459 / 459 | 99% | 39.20 | 1112 / 1118 |
bladder | 100% | 1677.29 | 21 / 21 | 99% | 33.55 | 501 / 504 |
esophagus | 100% | 1114.95 | 1441 / 1445 | 99% | 40.52 | 182 / 183 |
prostate | 100% | 1932.39 | 245 / 245 | 98% | 17.80 | 494 / 502 |
pancreas | 97% | 937.06 | 318 / 328 | 99% | 39.85 | 177 / 178 |
adrenal gland | 100% | 1212.09 | 258 / 258 | 91% | 15.70 | 209 / 230 |
liver | 95% | 930.04 | 215 / 226 | 93% | 15.93 | 378 / 406 |
skin | 99% | 1778.82 | 1793 / 1809 | 76% | 17.19 | 360 / 472 |
adipose | 100% | 2292.21 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 165.72 | 29 / 29 |
spleen | 100% | 5705.57 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 42.73 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.66 | 1 / 1 |
blood vessel | 100% | 2626.50 | 1330 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 1250.83 | 795 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 4333.99 | 912 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 937.17 | 845 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 83% | 12.28 | 66 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005764 | Cellular component | lysosome |
GO_0031090 | Cellular component | organelle membrane |
GO_0005768 | Cellular component | endosome |
GO_0031902 | Cellular component | late endosome membrane |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005770 | Cellular component | late endosome |
GO_0019899 | Molecular function | enzyme binding |
GO_0005515 | Molecular function | protein binding |
Gene name | VOPP1 |
Protein name | WW domain binding protein VOPP1 (EGFR-coamplified and overexpressed protein) (Vesicular, overexpressed in cancer, prosurvival protein 1) WW domain binding protein VOPP1 (EGFR-coamplified and overexpressed protein) (ECop) (Glioblastoma-amplified secreted protein) (Putative NF-kappa-B-activating protein 055N) (Vesicular, overexpressed in cancer, prosurvival protein 1) VOPP1 WW domain binding protein |
Synonyms | ECOP GASP |
Description | FUNCTION: Increases the transcriptional activity of NFKB1 by facilitating its nuclear translocation, DNA-binding and associated apoptotic response, when overexpressed . May sequester WWOX in lysosomal vesicles and thereby regulate WWOX role as tumor suppressor . . |
Accessions | ENST00000625836.2 [Q96AW1-3] ENST00000428648.5 ENST00000454227.5 C9JVH1 C9JQ18 C9J827 ENST00000417399.5 ENST00000418904.5 [Q96AW1-4] ENST00000427700.1 C9JF99 ENST00000453256.5 ENST00000452832.5 C9JTY8 C9JIM1 ENST00000414113.5 ENST00000428097.5 ENST00000285279.10 [Q96AW1-1] ENST00000433959.5 [Q96AW1-2] ENST00000455023.5 C9J548 Q96AW1 |